Contents


Contents


Copyright


Dedication


Acknowledgments


About the Editors


Contributing Authors


Chapter 1      Introduction
Jessica R. Allegretti, MD, MPH and Zain Kassam, MD, MPH


Chapter 2      Microbiome 101
Suzanne Devkota, PhD


Chapter 3      The History of Fecal Microbiota Transplantation
Joann Kwah, MD, FACG and Lawrence J. Brandt, MD, MACG, AGAF, FASGE


Chapter 4      Decision: Which Patients With Clostridioides difficile Infection Are Appropriate for Fecal Microbiota Transplantation?
Abbas Rupawala, MD and Colleen R. Kelly, MD


Chapter 5      Decision: Considerations for Use of Fecal Microbiota Transplantation in Special Patient Populations
Rohma Ghani, MBBS, MRCP and Benjamin H. Mullish, MB, BChir, MRCP, PhD


Chapter 6      Donor: How Do You Select and Screen Candidate Donors for Fecal Microbiota Transplantation?
Shrish Budree, MBChB, DCH, FCPaeds, Cert. Paeds Gastro.


Chapter 7      Discussion: How Do You Discuss the Risks and Benefits of Fecal Microbiota Transplantation?
Majdi Osman, MD, MPH and Pratik Panchal, MD, MPH


Chapter 8      Delivery: How Do You Select the Most Appropriate Delivery Modality for Fecal Microbiota Transplantation?
Paul Feuerstadt, MD, FACG, AGAF and Neil Stollman, MD, FACP, FACG, AGAF


Chapter 9      Discharge: How Should You Follow and Care for Patients After Fecal Microbiota Transplantation?
Lauren Tal Grinspan, MD, PhD and Ari M. Grinspan, MD


Chapter 10    Discovery: Emerging Indications
Jessica R. Allegretti, MD, MPH and Zain Kassam, MD, MPH


10.1 | Other Clostridioides difficile Indications


10.1.1 | The Role of Fecal Microbiota Transplantation in the Treatment of Primary Clostridioides difficile Infection
Alexander Khoruts, MD


10.1.2 | The Role of Fecal Microbiota Transplantation in the Treatment of Severe and Fulminant Clostridioides difficile Infection
Monika Fischer, MD, MSc and Sára Nemes, BA


10.2 | Gastrointestinal Indications: What Have We Learned?


10.2.1 | The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
Lindsey Russell, MD, MSc and Paul Moayyedi, MD, PhD, MPH


10.2.2 | The Role of Fecal Microbiota Transplantation in the Treatment of Pouchitis
Jennifer D. Claytor, MD, MS and Najwa El-Nachef, MD


10.2.3 | The Role of Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome
Neena Malik, MD, MSc and Olga C. Aroniadis, MD, MSc


10.3 | The Role of Fecal Microbiota Transplantation in the Treatment of Liver Diseases
Chathur Acharya, MD and Jasmohan S. Bajaj, MD, MS


10.4 | The Role of Fecal Microbiota Transplantation in the Treatment of Autism Spectrum Disorder
Thomas J. Borody, MD, PhD, DSc and Anoja W. Gunaratne, BAMS (Hon), MSc, PhD


10.5 | The Role of Fecal Microbiota Transplantation in the Decolonization of Antibiotic-Resistant Bacteria
Christopher Saddler, MD and Nasia Safdar, MD, PhD


10.6 | The Role of Fecal Microbiota Transplantation in the Treatment of Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease
Benjamin H. Mullish, MB, BChir, MRCP, PhD


Chapter 11    Frequently Asked Questions
Jessica R. Allegretti, MD, MPH and Zain Kassam, MD, MPH


Financial Disclosures

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 23, 2021 | Posted by in GASTROENTEROLOGY | Comments Off on Contents

Full access? Get Clinical Tree

Get Clinical Tree app for offline access